A study to assess the pharmacokinetics of Camizestrant (AZD9833) when Administered Alone and in Combination with Itraconazole

Trial Identifier:	D8532C00003
Sponsor:	AstraZeneca
Collaborator:	Parexel
NCTID::	NCT05551897
Start Date:	October 2022
Primary Completion Date:	December 2022
Study Completion Date:	December 2022
Condition:	Healthy Volunteers

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language	Description
	English Version

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
GB	Harrow, GB, HA1 3UJ

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.